Jane Street Group, LLC Immunity Bio, Inc. Transaction History

Jane Street Group, LLC

$481 Billion
Q2 2025

A detailed history of Jane Street Group, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 7,718,265 shares of IBRX stock, worth $19.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,718,265

Previous 129,363 5866.36%

Holding current value

$19.1 Million

Previous $389,000 5138.05%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.89 - $3.44 $14.3 Million - $26.1 Million	7,588,902 Added 5866.36%	7,718,265 $20.4 Million
Q1 2025 May 14, 2025	SELL	$2.32 - $3.9 $284,691 - $478,576	-122,712 Reduced 48.68%	129,363 $389,000
Q4 2024 Feb 14, 2025	BUY	$2.56 - $6.17 $400,552 - $965,395	156,466 Added 163.65%	252,075 $645,000
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $5.38 Million - $10.9 Million	-1,620,450 Reduced 94.43%	95,609 $354,000
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $6.79 Million - $12.9 Million	1,407,921 Added 456.91%	1,716,059 $10.8 Million
Q1 2024 May 15, 2024	SELL	$3.23 - $6.17 $1.66 Million - $3.17 Million	-513,505 Reduced 62.5%	308,138 $1.65 Million
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $1.03 Million - $4.28 Million	821,643 New	821,643 $4.12 Million
Q2 2023 Aug 14, 2023	SELL	$1.53 - $6.41 $119,376 - $500,133	-78,024 Reduced 34.71%	146,732 $407,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $240,159 - $850,342	177,896 Added 379.63%	224,756 $409,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $121,739 - $189,465	27,986 Added 148.28%	46,860 $237,000
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.43 $86,618 - $152,590	-23,731 Reduced 55.7%	18,874 $94,000
Q2 2022 Aug 16, 2022	SELL	$2.68 - $6.14 $286,762 - $656,986	-107,001 Reduced 71.52%	42,605 $159,000
Q1 2022 May 17, 2022	BUY	$5.05 - $7.53 $618,135 - $921,694	122,403 Added 449.96%	149,606 $840,000
Q4 2021 Feb 15, 2022	BUY	$5.67 - $10.18 $85,872 - $154,176	15,145 Added 125.6%	27,203 $165,000
Q3 2021 Nov 16, 2021	SELL	$9.17 - $14.24 $164,968 - $256,177	-17,990 Reduced 59.87%	12,058 $118,000
Q2 2021 Aug 16, 2021	SELL	$13.41 - $22.4 $168,000 - $280,627	-12,528 Reduced 29.43%	30,048 $429,000
Q1 2021 May 18, 2021	BUY	$12.83 - $42.25 $546,250 - $1.8 Million	42,576 New	42,576 $1.01 Million

Others Institutions Holding IBRX

# of Institutions

275

Shares Held

111M

Call Options Held

1.99M

Put Options Held

3.09M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $989M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Immunity Bio, Inc. Transaction History